Experimental Models of In Vitro Blood–Brain Barrier for CNS Drug Delivery: An Evolutionary Perspective
International Journal of Molecular Sciences · 31.01.2023 · 24 (3) · 2710
DOI: 10.3390/ijms24032710 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 31.01.2023. Verfasst von Bivek Chaulagain und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, School of Pharmacy, College of Health Professions, North Dakota State University, Fargo, ND 58105, USA. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Central Nervous System Diseases. Die Arbeit wurde bisher 79-mal zitiert (Crossref) und nennt 186 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIGMS NIH HHS, DaCCoTA CTR pilot ready-to-go grant.
Abstract (Originalsprache)
Central nervous system (CNS) disorders represent one of the leading causes of global health burden. Nonetheless, new therapies approved against these disorders are among the lowest compared to their counterparts. The absence of reliable and efficient in vitro blood–brain barrier (BBB) models resembling in vivo barrier properties stands out as a significant roadblock in developing successful therapy for CNS disorders. Therefore, advancement in the creation of robust and sensitive in vitro BBB models for drug screening might allow us to expedite neurological drug development. This review discusses the major in vitro BBB models developed as of now for exploring the barrier properties of the cerebral vasculature. Our main focus is describing existing in vitro models, including the 2D transwell models covering both single-layer and co-culture models, 3D organoid models, and microfluidic models with their construction, permeability measurement, applications, and limitations. Although microfluidic models are better at recapitulating the in vivo properties of BBB than other models, significant gaps still exist for their use in predicting the performance of neurotherapeutics. However, this comprehensive account of in vitro BBB models can be useful for researchers to create improved models in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, School of Pharmacy, College of Health Professions, North Dakota State University, Fargo, ND 58105, USA.
ORCID-Profile: Richard Nii Lante Lamptey, Buddhadev Layek
Förderung
- NIA NIH HHS
- NIGMS NIH HHS
- DaCCoTA CTR pilot ready-to-go grant
- National Institute of Health
- NIGMS COBRE
- DaCCoTA CTR pilot ready-to-go
Zitieren
APA
Chaulagain, B., Gothwal, A., Lamptey, R. N. L., Trivedi, R., Mahanta, A. K., Layek, B., & Singh, J. (2023). Experimental Models of In Vitro Blood–Brain Barrier for CNS Drug Delivery: An Evolutionary Perspective. International Journal of Molecular Sciences, 24(3), 2710. https://doi.org/10.3390/ijms24032710
Vancouver
Chaulagain B, Gothwal A, Lamptey RNL, Trivedi R, Mahanta AK, Layek B, et al. Experimental Models of In Vitro Blood–Brain Barrier for CNS Drug Delivery: An Evolutionary Perspective. International Journal of Molecular Sciences. 2023;24(3):2710. doi:10.3390/ijms24032710
BibTeX
@article{Chaulagain2023,
author = {Chaulagain, Bivek and Gothwal, Avinash and Lamptey, Richard Nii Lante and Trivedi, Riddhi and Mahanta, Arun Kumar and Layek, Buddhadev and Singh, Jagdish},
title = {Experimental Models of In Vitro Blood–Brain Barrier for CNS Drug Delivery: An Evolutionary Perspective},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {3},
pages = {2710},
doi = {10.3390/ijms24032710}
}
EUVIMED